Skip to main content

Table 3 Day 28 PCR-uncorrected study endpoints for children enrolled

From: Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015–2017

Antimalarial drug

Treatment outcome

Sentinel site

Total

WRH

NWMH

YMH

SMH

BMH

BGH

HMH

TAGH

LEKMH

EWP

AS–AQ

 

n = 51

n = 55

n = 0

n = 54

n = 63

n = 62

n = 61

n = 61

n = 23

n = 62

N = 492

ETF

0

1

0

0

0

0

0

0

0

1

LCF

0

0

0

0

0

0

0

0

0

0

LPF

0

0

0

1

1

0

0

0

4

6

ACPR

45

54

51

62

58

58

60

20

58

466

LFU

5

0

3

0

3

3

1

3

0

18

WTH

1

0

0

0

0

0

0

0

0

1

Antimalarial drug

Treatment outcome

Sentinel site

Total

WRH

NWMH

YMH

SMH

BMH

BGH

HMH

TAGH

LEKMH

EWP

AL

 

n = 0

n = 58

n = 60

n = 43

n = 63

n = 63

n = 60

n = 58

n = 0

n = 67

N = 472

ETF

0

0

1

0

0

0

2

0

3

LCF

0

0

0

1

1

0

0

0

2

LPF

5

3

3

3

1

0

12

9

36

ACPR

53

54

39

59

57

47

42

54

405

LFU

0

0

0

0

2

13

2

1

18

WTH

0

3

0

0

2

0

0

3

8

  1. WRH Wa Regional Hospital, NWMH Navrongo War Memorial Hospital, YMH Yendi Municipal Hospital, SMH Sunyani Municipal Hospital, BMH Bekwai Municipal Hospital, BGH Begoro Government Hospital, HMH Hohoe Municipal Hospital, TAGH Tarkwa Apinto Government Hospital, LEKMH Ledzokuku-Krowor Municipal Hospital, EWP Ewim Polyclinic, ETF early treatment failure, LCF late clinical failure, LPF late parasitological failure, ACPR adequate clinical and parasitological response, LFU loss to follow-up, WTH withdrawn